Enhancement of Pressure Healing With Pulsatile Lavage

Sponsor
US Department of Veterans Affairs (U.S. Fed)
Overall Status
Completed
CT.gov ID
NCT00047619
Collaborator
(none)
28
1
2
71
0.4

Study Details

Study Description

Brief Summary

The purpose of this study is to investigate the use of pulsatile lavage to enhance the healing of pressure ulcers in individuals with spinal cord injury (SCI).

The goals will be achieved using a repeated-measures double-blinded randomized controlled study of individuals with SCI who have pelvic region pressure ulcers. A total of 60 subjects will be recruited to this study. Participants will be randomly assigned to a treatment or control group. Pulsatile lavage treatment will be administered to the treatment group daily for a 3 week period. The control group subjects will receive daily sham pulsatile lavage treatment for 3 weeks. All subjects will be monitored for a 3 week period and will continue to receive routine pressure ulcer care, i.e. dressings and bedrest with a regular turning regime during their participation in the study.

All study participants will be monitored following the study period until complete closure of the pressure ulcer is achieved in order to determine total interval to final closure, including any surgical procedures required. In addition, the economic effects of pulsatile lavage treatment will be evaluated through monitoring of data collected in the Computerized Patient Record System (CPRS), including duration of admission, duration of total bedrest order and duration of treatment for pressure ulcer. This data will give an initial measure of the cost benefits that may be achieved with the use of pulsatile lavage for the treatment of pressure ulcers.

Subjects will be recruited from the Louis Stokes Cleveland Veterans Affairs Medical Center (CVAMC). All individuals with spinal cord injury who are admitted to the SCI Unit with pelvic region pressure ulcers will be considered eligible for this study. Further selection criteria will be employed to screen potential participants as described below. On recruitment subjects will be randomly assigned to 2 groups of 20 subjects. The assessment methods employed will be the same for each volunteer. One group will participate in the pulsatile lavage intervention, the second group will act as controls.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Pulsatile Lavage
  • Other: sham pulsatile lavage
Phase 2

Detailed Description

The purpose of this study is to investigate the use of pulsatile lavage to enhance the healing of pressure ulcers in individuals with spinal cord injury (SCI). It will investigate the hypothesis that the treatment of non-necrotic pressure ulcers with pulsatile lavage will enhance the rate of healing.

These goals will be achieved using a repeated-measures double-blinded randomized controlled study of individuals with SCI who have pelvic region pressure ulcers. A total of 60 subjects will be recruited to this study. Participants will be randomly assigned to a treatment or control group. Pulsatile lavage treatment will be administered to the treatment group daily for a 3 week period. The control group subjects will receive daily sham pulsatile lavage treatment for 3 weeks. All subjects will be monitored for a 3 week period and will continue to receive routine pressure ulcer care, i.e. dressings and bedrest with a regular turning regime during their participation in the study.

All study participants will be monitored following the study period until complete closure of the pressure ulcer is achieved in order to determine total interval to final closure, including any surgical procedures required. In addition, the economic effects of pulsatile lavage treatment will be evaluated through monitoring of data collected in CPRS, including duration of admission, duration of total bedrest order and duration of treatment for pressure ulcer. This data will give an initial measure of the cost benefits that may be achieved with the use of pulsatile lavage for the treatment of pressure ulcers.

Methodology Eligible individuals with SCI who are admitted to CVAMC with pelvic region pressure ulcers will be assigned to a pulsatile lavage treatment group or to a second non-intervention control group. A comprehensive assessment methodology will be employed to characterize pressure ulcer healing. All study participants will be assessed at routine intervals using objective measurement techniques. Statistical analysis of inter-group differences will allow the efficacy of pulsatile lavage for pressure ulcer healing to be established. Forty subjects will be enrolled in the study.

Patient Selection Criteria: Subjects will be recruited from the Louis Stokes Cleveland Veterans Affairs Medical Center (CVAMC). All individuals with spinal cord injury who are admitted to the SCI Unit with pelvic region pressure ulcers will be considered eligible for this study. Further selection criteria will be employed to screen potential participants as described below. On recruitment subjects will be randomly assigned to 2 groups of 20 subjects. The assessment methods employed will be the same for each volunteer. One group will participate in the pulsatile lavage intervention, the second group will act as controls.

Study Design

Study Type:
Interventional
Actual Enrollment :
28 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Enhancement of Pressure Healing With Pulsatile Lavage
Study Start Date :
Jun 1, 2002
Actual Primary Completion Date :
May 1, 2008
Actual Study Completion Date :
May 1, 2008

Arms and Interventions

Arm Intervention/Treatment
Experimental: Pulsatile lavage group

pulsatile lavage therapy

Procedure: Pulsatile Lavage
pulsatile lavage to wound bed

Sham Comparator: Sham lavage group

sham pulsatile lavage

Other: sham pulsatile lavage
pulsatile lavage to not directed at wound or patient

Outcome Measures

Primary Outcome Measures

  1. Pressure Ulcer Geometry [study participation - up to 6 weeks]

    Linear assessment of wounds

  2. Pressure Ulcer Volume Measurement [study participation - up to 6 weeks]

    Volume of pressure ulcer was measured by the amount of fluid that could be used to fill the pressure ulcer which was covered by an occlusive dressing

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

Spinal Cord Injury

Exclusion Criteria:

systemic disease

Contacts and Locations

Locations

Site City State Country Postal Code
1 VA Medical Center, Cleveland Cleveland Ohio United States 44106

Sponsors and Collaborators

  • US Department of Veterans Affairs

Investigators

  • Principal Investigator: Chester H. Ho, MD, VA Medical Center, Cleveland

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
US Department of Veterans Affairs
ClinicalTrials.gov Identifier:
NCT00047619
Other Study ID Numbers:
  • A2803-R
First Posted:
Oct 10, 2002
Last Update Posted:
Oct 5, 2015
Last Verified:
Sep 1, 2015
Keywords provided by US Department of Veterans Affairs
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail
Arm/Group Title Pulsatile Lavage Group Sham Lavage Group
Arm/Group Description pulsatile lavage therapy Pulsatile Lavage: pulsatile lavage to wound bed sham pulsatile lavage sham pulsatile lavage: pulsatile lavage to not directed at wound or patient
Period Title: Overall Study
STARTED 14 14
COMPLETED 14 14
NOT COMPLETED 0 0

Baseline Characteristics

Arm/Group Title Pulsatile Lavage Group Sham Lavage Group Total
Arm/Group Description pulsatile lavage therapy Pulsatile Lavage: pulsatile lavage to wound bed sham pulsatile lavage sham pulsatile lavage: pulsatile lavage not directed at wound or patient Total of all reporting groups
Overall Participants 14 14 28
Age, Customized (participants) [Number]
Number of subjects >=18 years
14
100%
14
100%
28
100%
Sex/Gender, Customized (participants) [Number]
male gender
14
100%
14
100%
28
100%

Outcome Measures

1. Primary Outcome
Title Pressure Ulcer Geometry
Description Linear assessment of wounds
Time Frame study participation - up to 6 weeks

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Pulsatile Lavage Group Sham Lavage Group
Arm/Group Description pulsatile lavage therapy Pulsatile Lavage: pulsatile lavage to wound bed sham pulsatile lavage sham pulsatile lavage: pulsatile lavage to not directed at wound or patient
Measure Participants 14 14
Length in cm
3.5
4.9
Width in cm
2.9
3.0
Depth in cm
1.4
2.5
2. Primary Outcome
Title Pressure Ulcer Volume Measurement
Description Volume of pressure ulcer was measured by the amount of fluid that could be used to fill the pressure ulcer which was covered by an occlusive dressing
Time Frame study participation - up to 6 weeks

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Pulsatile Lavage Group Sham Lavage Group
Arm/Group Description pulsatile lavage therapy Pulsatile Lavage: pulsatile lavage to wound bed sham pulsatile lavage sham pulsatile lavage: pulsatile lavage to not directed at wound or patient
Measure Participants 14 14
Mean (95% Confidence Interval) [cm^3]
5.8
12.4

Adverse Events

Time Frame Duration of study
Adverse Event Reporting Description
Arm/Group Title Pulsatile Lavage Group Sham Lavage Group
Arm/Group Description pulsatile lavage therapy Pulsatile Lavage: pulsatile lavage to wound bed sham pulsatile lavage sham pulsatile lavage: pulsatile lavage to not directed at wound or patient
All Cause Mortality
Pulsatile Lavage Group Sham Lavage Group
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total / (NaN) / (NaN)
Serious Adverse Events
Pulsatile Lavage Group Sham Lavage Group
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/14 (0%) 0/14 (0%)
Other (Not Including Serious) Adverse Events
Pulsatile Lavage Group Sham Lavage Group
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/14 (0%) 0/14 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Dr. Chester Ho
Organization University of Calgary
Phone (403) 944 4620
Email chester.ho@albertahealthservices.ca
Responsible Party:
US Department of Veterans Affairs
ClinicalTrials.gov Identifier:
NCT00047619
Other Study ID Numbers:
  • A2803-R
First Posted:
Oct 10, 2002
Last Update Posted:
Oct 5, 2015
Last Verified:
Sep 1, 2015